Sort
326,823 grants matching “clinical trial”
(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank
$2,532,378Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2025 · CA
Epitope-targeted Vaccines for HIV-1 Prevention
$2,532,157Xiangpeng Kong · New York University School Of Medicine · P01 · FY2013 · AI
TAS::75 0872::TAS SMARTT (11-8470187)
$2,531,501Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · HL
Community Ambulation Following Hip Fracture
$2,531,155Jay Steven Magaziner · University Of Maryland Baltimore · R01 · FY2012 · AG
Yale Comprehensive Cancer Center Support Grant
$2,531,005Thomas James Lynch · Yale University · P30 · FY2013 · CA
PumpKIN PreClinical
$2,531,000Robert Jarvik · Jarvik Heart, Inc. · N01 · FY2011 · HL
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,530,690Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,530,688Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA
Monoclonal Antibody-based Multipurpose Microbicides
$2,530,562Deborah J Anderson · Boston University Medical Campus · U19 · FY2014 · AI
HSV-1 Amplicon Vectors for HIV Vaccine Delivery
$2,530,347University Of Rochester · P01 · FY2005 · AI
Cellular Control: Synthetic Signaling/Motility (RMI)
$2,530,000Wendell A Lim · University Of California, San Francisco · PN2 · FY2010 · EY
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,529,238Robert Stanley Sherwin · Yale University · UL1 · FY2011 · RR
SWOG Network Group Operations Center of the NCTN
$2,529,157Charles D. Blanke · Oregon Health & Science University · U10 · FY2024 · CA
ECOG Statistical Office Data Management Grant
$2,529,153Robert J Gray · Frontier Sci & Technology Rsch Fdn, Inc · U10 · FY2007 · CA
CANCER CENTER SUPPORT GRANT
$2,529,146Gerold Bepler · Wayne State University · P30 · FY2015 · CA
Next Generation HSC Gene Therapy for HIV Control and Eradication
$2,529,095Paula M Cannon · University Of Southern California · U19 · FY2019 · HL
Next Generation HSC Gene Therapy for HIV Control and Eradication
$2,529,095Paula M Cannon · University Of Southern California · U19 · FY2018 · HL
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV
$2,529,017Niranjan Sardesai · Viral Genomix, Inc. · N01 · FY2012 · AI
Disrupted Adenovirus Serotype 5-based Anti-cocaine Vaccine
$2,528,781Ronald G Crystal · Weill Medical Coll Of Cornell Univ · U01 · FY2013 · DA
Autoimmunity Centers of Excellence
$2,528,506Yeshiva University · U19 · FY2003 · AI
Preclinical drug development in pancreatic cancer
$2,528,211Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center
$2,528,056Tony Moody · Duke University · N01 · FY2024 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center
$2,528,056Tony Moody · Duke University · N01 · FY2024 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center
$2,528,056Tony Moody · Duke University · N01 · FY2024 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center
$2,528,056Tony Moody · Duke University · N01 · FY2024 · AI